Skip to main content
Erschienen in: Documenta Ophthalmologica 3/2017

12.09.2017 | Clinical Case Report

Electrophysiological features and multimodal imaging in ritonavir-related maculopathy

verfasst von: Céline Faure, Michel Paques, Isabelle Audo

Erschienen in: Documenta Ophthalmologica | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study is to report a case of ritonavir-related retinal toxicity followed over a year. Electrophysiological features and multimodal imaging, including adaptive optics, are provided and discussed.

Methods

Electrophysiological recordings and multimodal imaging were performed and repeated over 1 year.

Results

Fundus examination revealed crystalline maculopathy in conjunction with pigment disruption. Spectral domain optical coherence tomography displayed thinning of the macula without cysts. Autofluorescence imaging revealed a mixed pattern of complete loss of the autofluorescence in the area of retinal pigment deposit and an increased transmission of the autofluorescence in the area of retinal thinning. Fluorescein angiography ruled out parafoveal telangiectasia. Indocyanine green angiography was not contributive. Increased spacing of the macular cone mosaic, crystal deposits and pigment migrations were seen with adaptive optics. Full-field electroretinogram was slightly reduced for both eyes, especially in the light-adapted responses, and mfERG confirmed bilateral maculopathy. Functional and structural abnormalities did not change with follow-up besides constant pigmentary changes monitored with adaptive optics.

Conclusion

Ritonavir-related retinal toxicity is a maculopathy with peculiar features including crystalline and pigment migration associated with central or temporofoveolar thinning and inconstant macular telangiectasia. Despite drug cessation, retinal remodelling continues to progress.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Roe RH, Jumper JM, Gualino V, Wender J, McDonald HR, Johnson RN, Fu AD, Cunningham ET Jr (2011) Retinal pigment epitheliopathy, macular telangiectasis, and intraretinal crystal deposits in HIV-positive patients receiving ritonavir. Retina 31:559–565CrossRefPubMed Roe RH, Jumper JM, Gualino V, Wender J, McDonald HR, Johnson RN, Fu AD, Cunningham ET Jr (2011) Retinal pigment epitheliopathy, macular telangiectasis, and intraretinal crystal deposits in HIV-positive patients receiving ritonavir. Retina 31:559–565CrossRefPubMed
2.
Zurück zum Zitat Leiner S (2012) Re: retinal pigment epitheliopathy, macular telangiectasis, and intraretinal crystal deposits in HIV-positive patients receiving ritonavir. Retina 32(2):411CrossRefPubMed Leiner S (2012) Re: retinal pigment epitheliopathy, macular telangiectasis, and intraretinal crystal deposits in HIV-positive patients receiving ritonavir. Retina 32(2):411CrossRefPubMed
4.
Zurück zum Zitat McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, Bach M (2015) ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol 130(1):1–12CrossRefPubMed McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, Bach M (2015) ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol 130(1):1–12CrossRefPubMed
5.
Zurück zum Zitat Biancardi AL, Curi ALL (2016) Retinal toxicity related to long-term use of ritonavir. Retina 36:229–231CrossRefPubMed Biancardi AL, Curi ALL (2016) Retinal toxicity related to long-term use of ritonavir. Retina 36:229–231CrossRefPubMed
6.
7.
Zurück zum Zitat Gocho K, Sarda V, Falah S, Sahel JA, Sennlaub F, Benchaboune M, Ullern M, Paques M (2013) Adaptive optics imaging of geographic atrophy. Invest Ophthalmol Vis Sci 54:3673–3680CrossRefPubMed Gocho K, Sarda V, Falah S, Sahel JA, Sennlaub F, Benchaboune M, Ullern M, Paques M (2013) Adaptive optics imaging of geographic atrophy. Invest Ophthalmol Vis Sci 54:3673–3680CrossRefPubMed
8.
Zurück zum Zitat Fawzi AA, Lee NG, Eliott D, Song J, Stewart JM (2009) Retinal findings in patients with Alport Syndrome: expanding the clinical spectrum. Br J Ophthalmol 93(12):1606–1611CrossRefPubMed Fawzi AA, Lee NG, Eliott D, Song J, Stewart JM (2009) Retinal findings in patients with Alport Syndrome: expanding the clinical spectrum. Br J Ophthalmol 93(12):1606–1611CrossRefPubMed
9.
Zurück zum Zitat Vadlapatla RK, Vadlapudi AD, Pal D, Mukherji M, Mitra AK (2014) Ritonavir inhibits HIF-1α-mediated VEGF expression in retinal pigment epithelial cells in vitro. Eye (Lond) 28(1):93–101CrossRef Vadlapatla RK, Vadlapudi AD, Pal D, Mukherji M, Mitra AK (2014) Ritonavir inhibits HIF-1α-mediated VEGF expression in retinal pigment epithelial cells in vitro. Eye (Lond) 28(1):93–101CrossRef
Metadaten
Titel
Electrophysiological features and multimodal imaging in ritonavir-related maculopathy
verfasst von
Céline Faure
Michel Paques
Isabelle Audo
Publikationsdatum
12.09.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Documenta Ophthalmologica / Ausgabe 3/2017
Print ISSN: 0012-4486
Elektronische ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-017-9612-z

Weitere Artikel der Ausgabe 3/2017

Documenta Ophthalmologica 3/2017 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.